Pontus Eriksson

Sökresultat

• 2022

  Reply to Joep J. de Jong and Ewan A. Gibb's Letter to the Editor re: Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81:316-7. Neoadjuvant Chemotherapy Response in Muscle-invasive Bladder Cancer: Differences in Intrinsic Biology or Subtyping Nomenclature?

  Sjödahl, G., Abrahamsson, J., Holmsten, K., Bernardo, C., Eriksson, P., Kollberg, P., Marzouka, N. A. D., Höglund, M., Ullén, A. & Liedberg, F., 2022 apr., I: European Urology. 81, 4, s. e92-e93

  Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
• 2020

  Re: A. Gordon Robertson, Clarice S. Groeneveld, Brian Jordan, et al. Identification of Differential Tumor Subtypes of T1 Bladder Cancer. Eur Urol. In press. http://doi.org/10.1016/j.eururo.2020.06.048

  Liedberg, F., Eriksson, P. & Sjödahl, G., 2020 dec., I: European Urology. 78, 6, s. e228-e229 2 s.

  Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
• 2019

  Re: Tuan Zea Tan, Mathieu Rouanne, Kien Thiam Tan, Ruby Yun-Ju Huang, Jean-Paul Thiery. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors. Eur Urol 2019;75:423–32

  Eriksson, P. & Sjödahl, G., 2019, I: European Urology. 75, 4, s. e106-e107

  Forskningsoutput: Tidskriftsbidrag › Letter › Peer review